The Clinical Benefit of Ruxolitinib Across Patient Subgroups: Analysis of a Placebo-Controlled, Phase III Study in Patients With Myelofibrosis

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.12274
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy